Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Garber

Showing results (471-480 of 605) with videos related to

Pageof 61
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2019
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline UpdateKala Visvanathan, Carol J Fabian, Elissa Bantug, et al.
Journal of Pathology Informatics|August 31, 2012
The feasibility of using natural language processing to extract clinical information from breast pathology reportsJulliette M Buckley, Suzanne B Coopey, John Sharko, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
Cancer Research|April 6, 2006
Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesisGromoslaw A Smolen, Beth Muir, Gayatry Mohapatra, et al.
NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.
Journal of the National Cancer Institute|June 18, 2010
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancerJudy E Garber, Susan Halabi, Sara M Tolaney, et al.
Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.
Journal of the National Cancer Institute|April 3, 2024
TP53-associated early breast cancer: new observations from a large cohortRenata L Sandoval, Michele Bottosso, Li Tianyu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 StudySigne Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, et al.
Breast Cancer Research and Treatment|November 3, 2012
The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesionsSuzanne B Coopey, Emanuele Mazzola, Julliette M Buckley, et al.
Pageof 61

Showing results (471-480 of 605) with videos related to

Sort By:
Pageof 61
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2019
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline UpdateKala Visvanathan, Carol J Fabian, Elissa Bantug, et al.
Journal of Pathology Informatics|August 31, 2012
The feasibility of using natural language processing to extract clinical information from breast pathology reportsJulliette M Buckley, Suzanne B Coopey, John Sharko, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
Cancer Research|April 6, 2006
Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesisGromoslaw A Smolen, Beth Muir, Gayatry Mohapatra, et al.
NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.
Journal of the National Cancer Institute|June 18, 2010
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancerJudy E Garber, Susan Halabi, Sara M Tolaney, et al.
Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.
Journal of the National Cancer Institute|April 3, 2024
TP53-associated early breast cancer: new observations from a large cohortRenata L Sandoval, Michele Bottosso, Li Tianyu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 StudySigne Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, et al.
Breast Cancer Research and Treatment|November 3, 2012
The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesionsSuzanne B Coopey, Emanuele Mazzola, Julliette M Buckley, et al.
Pageof 61